Table 4.

Impact of BCA on the liver MDA level and antioxidant enzymatic activity of the rats with TAA-induced liver injury.

Treatment	MDA nmol/min/mg Protein	SOD U/mg Protein	CAT nmol/min/mg Protein	GPx nmol/min/mg Protein
Normal control	2.13 ± 0.05	26.13 ± 0.61	81.52 ± 2.84	371.42 ± 14.62
TAA control	10.24 ± 0.14 *	15.31 ± 1.82 *	34.71 ± 1.13 *	278.54 ± 7.51 *
Silymarin (50 mg/kg) + TAA	3.01 ± 0.20 **	24.45 ± 1.03 **	84.65 ± 0.24 **	353.77 ± 3.87 **
BCA 25 mg/kg + TAA	1.52 ± 0.12 **	19.25 ± 0.37 **	49.00 ± 4.51 **	310.59 ± 4.52 **
BCA 50 mg/kg + TAA	3.13 ± 1.46 **	24.70 ± 1.65 **	80.85 ± 5.14 **	349.30 ± 0.24 **

Data expressed as mean ± SEM (n = 6 rats/group). ** p < 0.05 compared with TAA control, * p < 0.05 compared with normal control.